Khoja Hamid's Form 4 filing
FibroBiologics, Inc. (FBLG) · filed Sep 15, 2026
- Accession no.
- 0001493152-26-042794
- Filed
- Sep 15, 2026, 7:26 PM ET
- Trade date
- Sep 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khoja HamidCIK 0002010662 | Officer (Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | AGrant or awardAcquired | +298,508 | $1.68F2 | +$500,000.9 | 301,571 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Common Stock | AGrant or awardAcquired | +298,508 | –F2 | – | 298,508 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Each share of Common Stock and accompanying Warrant were issued at a combined purchase price of $1.675.
Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.
Remarks
Exhibit 24 Power of Attorney